About the Company
at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BNGO News
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call March 5, 2024 Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, ...
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (“Bionano”) (Nasdaq: BNGO) today announced that is has amended the convertible debt financing the company entered into in October ...
BNGO Bionano Genomics, Inc.
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for ...
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase ...
Earnings Outlook For Bionano Genomics
Bionano Genomics BNGO is set to give its latest quarterly earnings report on Tuesday, 2024-03-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...
Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript
Good day and welcome to the Bionano Fourth Quarter and Full Year 2023 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to ...
Bionano Genomics Inc BNGO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Q4 2023 Bionano Genomics Inc Earnings Call
Good day. And welcome to the Bionano fourth quarter and full year 2023 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David ...
Bionano Genomics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Bionano Genomics Inc (BNGO)
Benzinga - by Vandana Singh, Benzinga Editor. Earlier today, Bionomics Limited (NASDAQ: BNOX) announced topline results from its Phase 2b ATTUNE trial of BNC210 for post-traumatic... BioNano Genomics ...
Bionano Genomics Inc (BNGO)
BioNano Genomics, Inc. (NASDAQ:BNGO) reported Q4 EPS of $, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.2 million versus the consensus... BioNano Genomics ...
Loading the latest forecasts...